Evidence map›Paper›PMID 37683644›Full record

ArticleStem cell reports2023

A feedforward loop between JAK/STAT downstream target p115 and STAT in germline stem cells.

Ruiyan Kong, Juan Li, Fuli Liu, Yankun Ma, Hang Zhao, Hanfei Zhao, Meifang Ma, Zhouhua Li

Abstract read
In one paragraph

Article in Stem cell reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ruiyan KongCollege of Life Sciences, Capital Normal University, Beijing 100048, China.
Juan LiCollege of Life Sciences, Capital Normal University, Beijing 100048, China.
Fuli LiuCollege of Life Sciences, Capital Normal University, Beijing 100048, China.
Yankun MaCollege of Life Sciences, Capital Normal University, Beijing 100048, China.
Hang ZhaoCollege of Life Sciences, Capital Normal University, Beijing 100048, China.
Hanfei ZhaoCollege of Life Sciences, Capital Normal University, Beijing 100048, China.
Meifang MaCollege of Life Sciences, Capital Normal University, Beijing 100048, China.
Zhouhua LiCollege of Life Sciences, Capital Normal University, Beijing 100048, China. Electronic address: zhli@cnu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The maintenance of germline stem cells (GSCs) is essential for tissue homeostasis. JAK/STAT signaling maintains GSC fate in Drosophila testis. However, how JAK/STAT signaling maintains male GSC fate through its downstream targets remains poorly understood. Here, we identify p115, a tER/cis-Golgi golgin protein, as a putative downstream target of JAK/STAT signaling. p115 maintains GSC fate independent of GM130 and GRASP65. p115 localizes in cytosol, the ER and Golgi apparatus in germline cells and is required for the morphology of the ER and Golgi apparatus. Furthermore, depletion of p115 in GSCs results in aberrant spindle orientation. Mechanistically, p115 associates with and stabilizes STAT. Finally, ectopic expression of STAT completely restores GSC loss caused by p115 depletion. Collectively, JAK/STAT signaling and p115 form a feedforward loop to maintain male GSC fate. Our work provides new insights into the regulatory mechanism of how stem cell maintenance is properly controlled by JAK/STAT signaling.

Indexed as

Drosophila ProteinsGerm CellsStem CellsAnimalsDrosophila melanogasterJanus KinasesMaleSignal TransductionSTAT Transcription FactorsDrosophila ProteinsJanus KinasesSTAT Transcription FactorsDam-IDdownstream targetDrosophilagermline stem cellJAK/STATmaintenancep115spindle orientationStat92Etestis

Identifiers

PMID37683644
PMCPMC10656303

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.